Confo Therapeutics
Ghent, Belgium · Founded 2015 · $67.1M raised
- Headquarters
- Ghent
- Founded
- 2015
- Website
- confotherapeutics.com
- Total Funding
- $67.1M
- Last Round
- $33.5M Series AMay 2019
- Rounds
- 2
About
Biotech company developing novel GPCR-targeting therapeutics using conformation-specific nanobodies.
Summary
Confo Therapeutics is a Biotechnology company based in Ghent, Belgium, founded in 2015. It has raised $67.1M in total across 2 rounds, most recently a $33.5M Series A round in May 2019.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2019
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Leading innovative radiopharmaceutical company in China developing next-generation radiopharmaceu...
Clinical-stage biotechnology company pioneering GPCR drug discovery through its proprietary Nativ...
Clinical-stage ophthalmic gene therapy company developing AAV-based treatments for rare and preva...
Belgian agricultural biotech company developing microbial-based biocontrol and biostimulant produ...
Clinical-stage biotechnology company developing in vivo CRISPR gene editing therapies for severe ...
Clinical-stage pharmaceutical development company.